PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2029934-0	1991	Effect of reserpine on the histochemical and biochemical properties of rat intestinal mucin.	Reserpine	10-19	solute carrier family 13 member 2	Rattus norvegicus	86-91	
2029934-2	1991	An assay for intestinal mucin sulfotransferase was developed and the activity shown to increase 3.4 times over control levels in rats given intraperitonal reserpine (0.5 mg/kg body wt) daily for 7 days.	Reserpine	155-164	solute carrier family 13 member 2	Rattus norvegicus	24-29	
2029934-8	1991	These findings are consistent with an action of reserpine causing an increased production of mucin which is enriched in glycoprotein components bearing sulfated oligosaccharide chains.	Reserpine	48-57	solute carrier family 13 member 2	Rattus norvegicus	93-98	
6569839-7	1984	On purification, the intracellular mucin of reserpine-treated rats had the same composition as mucin from control rats, but the former was smaller in size and had a higher specific radioactivity.	Reserpine	44-53	solute carrier family 13 member 2	Rattus norvegicus	35-40	
3609243-5	1987	Chronic reserpine treatment caused an increase in the sulfation of goblet cell mucin in the small intestine without accompanying morphological change; these findings resemble those reported in cystic fibrosis.	Reserpine	8-17	solute carrier family 13 member 2	Rattus norvegicus	79-84	
6569839-7	1984	On purification, the intracellular mucin of reserpine-treated rats had the same composition as mucin from control rats, but the former was smaller in size and had a higher specific radioactivity.	Reserpine	44-53	solute carrier family 13 member 2	Rattus norvegicus	95-100	
6795937-3	1981	Reserpine-treated rats contained 1.4 times more mucin in intestinal tissue than control rats (P less than 0.05) and incorporated [1-14C]glucosamine in vivo at 1.52 times the rate of controls (P less than 0.01).	Reserpine	0-9	solute carrier family 13 member 2	Rattus norvegicus	48-53	
6795937-6	1981	In vitro secretion of mucin was three times greater for reserpine-treated tissue than for control tissue (P less than 0.0001).	Reserpine	56-65	solute carrier family 13 member 2	Rattus norvegicus	22-27	
6795937-7	1981	There was an impairment in the mucin secretory response of reserpine-treated tissue to the addition of cholera toxin.	Reserpine	59-68	solute carrier family 13 member 2	Rattus norvegicus	31-36